mesoestetic Pharma Group
Xavier Font Martin is currently serving as the Co Managing Director & Legal Counsel at mesoestetic Pharma Group since 2020. Prior to this, they held the role of Institutional Relations & Legal Department at Mesoestetic from 2012 to 2021.
Xavier Font Martin completed a PDD (Program for Management Development) at IESE Business School in 2018. Prior to that, they obtained a degree in Law from the Universitat de Barcelona.
This person is not in any offices
mesoestetic Pharma Group
mesoestetic Pharma Group is a pharmaceutical laboratory internationally recognized as one of the leaders in the field of dermatology and aesthetic medicine offering innovative and efficient solutions for skin treatment and care. The company manufactures cosmeceutical, nutraceuticals, class III intradermal administration medical devices with CE conformity marking, topical drugs as well as energy based medical aesthetic devices. This full range of integral aesthetic solutions is characterized by a high degree of innovation and significant scientific contribution. Since its inception in 1984, the firm has been committed to meeting strict pharmaceutical standards and complying with the most stringent European regulations. The company facilities are authorized by the Spanish Agency for Medicines and Medical Devices (AEMYPS) and include three pharmaceutical manufacturing lines (cosmeceuticals and nutraceuticals / intradermal administration medical devices / injectable and topical drugs), as well as a Biotechnology Unit and a Monitoring and Follow-Up Unit. These units enable the company to cover the entire production cycle and carry out in vitro and in vivo studies to ensure the safety and efficacy of its products.